New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

Cureus, Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS- CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 - ScienceDirect

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

News & Comment Cellular & Molecular Immunology

Applications of genetic engineering in COVID-19

Frontiers Potential Therapeutic Targets and Vaccine Development for SARS- CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Applications of genetic engineering in COVID-19 - ScienceDirect

Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein - ScienceDirect

Browse Articles Cellular & Molecular Immunology

Articles in 2020 Cellular & Molecular Immunology

Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad